Aggressive Burkitt-Like Lymphoma of Colon in a Patient With Prior Celiac Disease by Ahluwalia, M. et al.
173
YALE JOURNAL OF BIOLOGY AND MEDICINE 79 (2006), pp.173-175.
Copyright © 2006.
CASE REPORT
Aggressive Burkitt-Like Lymphoma of Colon
in a Patient With Prior Celiac Disease
M. Ahluwaliaa, V. Gotlieba, V. Damerlab, and M. Wasif Saifc*
aHematology and Oncology, Brooklyn Hospital Center, Brooklyn, New York; bFlushing
Hospital Medical Center, Flushing, New York; cYale Cancer Center, Yale University
School of Medicine, New Haven, Connecticut
Background: Celiac disease (CD) and immunosuppression are the two risk factors for gas-
trointestinal, as well as non-gastrointestinal, non-Hodgkin’s lymphomas (NHL). Recent large
retrospective studies confirm that celiac disease significantly increases risk of developing
small bowel lymphomas by 30 to 40 percent and other gut malignancies by 83-fold. Case
Report: A 75-year-old man with a history of CD of two-year duration presented with pallor,
fatigue, and 20-pound weight loss of three weeks duration. There was a vague non-tender
mass in the right hypochondrium, and his stools tested positive for occult blood. The lab
values were within normal range, except for hemoglobin of 11mg/dL, MCV 75, mildly ele-
vated SGOT of 61 IU/L, and LDH of about 5000 IU/L. Work-up including computerized to-
mography (CT) scan, positron emission tomography (PET) scan, and colonoscopy were
performed. Results:ACT scan of the abdomen showed extensive carcinomatosis, scattered
lymphadenopathy, and small pleural effusions. PET scan results coincided with CT findings.
Colonoscopy revealed a friable nodular mass in the hepatic flexure, histopathology of which
confirmed a high-grade B-cell lymphoma. Flow cytometry following immunostaining was
positive for CD10, CD19, CD20, CD45, CD79a, and Ki-67. FISH assay demonstrated t
(14:18) translocation and bcl-2 rearrangement. The bone marrow biopsy showed evidence
of disease. The patient was treated with rituximab, plus cyclophosphamide,Adriamycin, vin-
cristine, and prednisone (CHOP-R), with intrathecal methotrexate prophylaxis. Currently,
the patient remains in remission. Conclusion: This is the first case of aggressive Burkitt-like
lymphoma (BLL) occurring in a patient with celiac disease in his eighth decade of life. It is
possible that chronic inflammation, profound immunosuppression, and nutritional deficit
could lead to development of high-grade B-cell lymphoproliferative disorders. Further mo-
lecular studies are warranted to the investigate the link between certain polymorphisms of
human leukocyte antigens (HLA) in B-cell populations in the gut, and this might be useful
to identify high-risk individuals in the population of patients with CD.
BACKGROUND
Celiac disease and immunosuppres-
sion are the two risk factors for gastroin-
testinal as well as non-gastrointestinal
non-Hodgkin’s lymphomas (NHL)†. Al-
though there has been conflicting data from
studies [1,2], recent large retrospective
studies confirm that celiac disease (CD)
significantly increases risk of developing
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sion tomography.small bowel lymphomas (more commonly
T-cell type) by 30 to 40 percent and other gut
malignancies by 83-fold [3,4]. Lymphoma
accounts for only 0.6 to 0.8 percent [4] of
colonic malignancies with one case of
Burkitt-like lymphoma (BLL) reported so
far [5].The possible mechanisms for the de-
velopment of lymphomas are not clear but
might be related to the chronic inflammation
of the bowel, leading to a sequential multi-
step process culminating in oncogenic muta-
tions. Here, we report a case of aggressive
BLLof the colon in a patient with prior CD.
CASE REPORT
A 75-year-old man with history of
celiac disease presented with pallor, fatigue,
and 20-pound weight loss of three weeks du-
ration. CD was diagnosed two years prior, at
which point the patient underwent extensive
evaluation for unexplained microcytic
hypochromic anemia and was found to have
an elevated endomysial antibody titer. A
small bowel biopsy showed celiac disease.
The patient was then placed on a gluten-free
diet and the anemia resolved completely.
On physical examination, a vague non-
tender mass in the right hypochondrium was
found and his stools tested positive for oc-
cult blood. The laboratory values were
within normal range, except for hemoglobin
(11mg/dL), MCV 75, SGOT (61 IU/L) and
LDH (5000 IU/L).
CT scan of abdomen showed extensive
carcinomatosis. There were also small pleu-
raleffusionsandscatteredlymphadenopathy.
PET showed diffusely hyper-metabolic foci
coinciding with CT findings. Colonoscopy
revealedafriablenodularmassinthehepatic
flexureandproximaltransversecolon.How-
ever, histopathologically the mass consisted
of a high-grade B-cell lymphoma. Flow cy-
tometry following immunostaining reported
positiveCD10,CD19,CD20,CD45,CD79a,
and Ki-67. FISH assay demonstrated t
(14:18) translocation and bcl-2 rearrange-
ment. The bone marrow biopsy showed evi-
dence of disease (Figure 1). The bone
marrow biopsy was also positive for CD10,
CD19, CD20, CD38, CD45 and HLA-DR.
The patient was treated with rituximab
cyclophosphamide,Adriamycin, vincristine,
and prednisone (CHOP-R) according to pro-
tocol, with intrathecal methotrexate prophy-
laxis. The patient is currently in remission.
DISCUSSION
This is one of the very few documented
cases of an aggressive colonic Burkitt-like
lymphoma in a patient with a history of
celiac disease. CD is an inflammatory con-
dition of the small intestine in which there
is gluten-mediated damage to small intes-
tinal villi. It is a common disorder affecting
as much as 1 percent of the population [6,7].
The association between CD and intestinal
lymphoma was first described by Fairley
and Mackie in 1937 [8]. A recent large
multi-center retrospective study involving
over 9,800 patients in Europe indicates that
celiac disease patients have an increased risk
of NHL (Odds ratio 2.6, 95 percent CI 1.4-
4.9) [4].
According to Catassi et al., enteropathy-
associated T-cell lymphoma is the most
common with an incidence rate of 0.5- to 1
million, constituting 35 percent of all small
bowel lymphomas, followed by B-cell and
adenocarcinomas [2]. Koo reported a case
of operable colonic lymphoma confined to
the transverse colon [5]. We report this rare
case in which a patient with a history of CD
developed colonic BLLwith extensive peri-
toneal involvement.There are three interest-
ing and unique features:While CD is usually
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Figure 1. Bone marrow examination
showed infiltration with B lymphocytes
coinciding with Burkitt’s-like lymphoma.a disease more common in the fourth and
fifth decades of life, our case was diagnosed
in his eighth decade. Secondly, his lym-
phoma was diagnosed two years after the di-
agnosis of celiac disease, in contrast to
literature, if celiac disease is diagnosed first,
lymphoma occurs within five to 10 years
with a probable time lag of up to 60 years
[9]. Lastly, the median age for incidence of
BLLis 55 years, while our patient was in his
eighth decade of life.
Several oncogenic mechanisms might
predispose the a digestive tract afflicted with
CD to malignancy: increased permeability
of environmental carcinogens like Epstein-
Barr virus, chronic inflammation, release of
pro-inflammatory cytokines, defective im-
mune surveillance (post-kidney transplant
and Human Immunodeficiency Virus pa-
tients) and nutritional deficiencies caused by
the disease or the gluten-free diet [10]. In-
creased ribosomal DNA transcriptional ac-
tivity in vitro in mucosal cells from patients
diagnosed with CD has been demonstrated
[11]. All the above-mentioned mechanisms
culminate in proneoplastic mutations in B-
cell populations such as deletion of 9p21,
17p23(P53) and gain of 1q chromosome.
Howell and associates have previously
demonstrated that apart from certain HLA
genotypes (DQA1*0501 and DQB1*0201)
predisposing to CD and EATCL, additional
HLA-DR/DQ alleles might independently
operate to cause lymphomas [12]. Likewise,
further molecular typing studies are war-
ranted to point out the nature of B-cell pop-
ulations in the gut in patients who develop
BLL. This can help to identify high-risk in-
dividuals among patient populations with di-
agnosed CD to aid in earlier therapeutic
intervention and better prognosis.
CONCLUSION
This is the first case of aggressive BLL
occurring in a patient with celiac disease in
his eighth decade of life. It is possible that
chronic inflammation from CD predisposes
individuals to the development of both high-
and low-grade B-cell lymphomas, although
this hypothesis is yet to be proven. Progno-
sis of these patients could be improved by
identifying certain unique HLA genotypes
associated with development of high grade
B-cell lymphomas by closer monitoring and
earlier intervention.
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